Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension.
OBJECTIVE
To determine whether local cardiac angiotensin converting enzyme (ACE) expression is upregulated during the development of hypoxia-induced right ventricular hypertrophy.


METHODS
ACE activity was measured in membrane preparations from the right ventricle and left ventricle plus septum in normoxic rats and animals exposed to chronic hypoxia for 8 and 14 days. Local cardiac ACE expression was studied by immunohistochemistry using a monoclonal antibody to ACE (9B9).


RESULTS
In the normal rat heart, ACE expression was confined to vascular endothelium, the valvular endocardium, and localized regions of parietal endocardium. We found that the development of pulmonary hypertension and right ventricular hypertrophy were associated with 2.6- and 3.4-fold increases in membrane-bound right ventricular ACE activity by 8 and 14 days of hypoxia, respectively. Right ventricular ACE activity was positively correlated with the degree of right ventricular hypertrophy (r = 0.83, P < 0.001). In contrast, left ventricular plus septal ACE activity was significantly reduced by approximately 40 and 60% by 8 and 14 days of hypoxia, respectively, compared to controls. In the right ventricle of chronically hypoxic rats, immunohistochemistry demonstrated increased ACE expression in areas of myocardial fibrosis. Interestingly, increased ACE expression was noted in the right ventricular epicardium in chronically hypoxic rats. In the free wall of the left ventricle there was a significant reduction in the number of myocardial capillaries which expressed ACE in chronically hypoxic rats.


CONCLUSIONS
Chronic hypoxia has a differential effect on left and right ventricular ACE activity and that the sites of altered ACE expression are highly localized. We speculate that locally increased right ventricular ACE activity and expression may play a role in the pathogenesis of right ventricular hypertrophy secondary to hypoxic pulmonary hypertension.
Morrell
N W
NW
Lung Developmental Biology Laboratory, University of Colorado Health Sciences Center, Denver 80262, USA.
Danilov
S M
SM
Satyan
K B
KB
Morris
K G
KG
Stenmark
K R
KR
D000818:Animals; D015415:Biomarkers; D004789:Enzyme Activation; D006352:Heart Ventricles; D006976:Hypertension, Pulmonary / Q000201:enzymology*; D017380:Hypertrophy, Right Ventricular / Q000201:enzymology*; D000860:Hypoxia / Q000201:enzymology*; D007150:Immunohistochemistry; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D015415:Biomarkers; D007703:Peptidyl-Dipeptidase A